Redmile Group, LLC Fate Therapeutics Inc Transaction History

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

A detailed history of Redmile Group, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Redmile Group, LLC holds 13,169,057 shares of FATE stock, worth $29.2 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
13,169,057
Previous 13,169,057 -0.0%
Holding current value
$29.2 Million
Previous $43.2 Million 6.71%
% of portfolio
3.01%
Previous 2.82%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.65 - $3.94 $73,639 - $175,842
44,630 Added 0.34%
13,169,057 $49.3 Million
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $795,895 - $1.1 Million
167,205 Added 1.29%
13,124,427 $62.5 Million
Q1 2021

May 17, 2021
BUY
$72.16 - $117.4 $23.6 Million - $38.4 Million
327,485 Added 2.59%
12,957,222 $1.07 Billion
Q2 2020

Aug 14, 2020
BUY
$20.21 - $35.23 $28.6 Million - $49.8 Million
1,412,928 Added 12.6%
12,629,737 $433 Million
Q3 2019

Nov 14, 2019
BUY
$15.47 - $22.5 $13.3 Million - $19.3 Million
857,143 Added 8.27%
11,216,809 $174 Million
Q4 2018

May 16, 2019
SELL
$11.48 - $16.98 $2.49 Million - $3.68 Million
-216,697 Reduced 2.05%
10,359,666 $133 Million
Q4 2018

Feb 14, 2019
BUY
$11.48 - $16.98 $2.49 Million - $3.68 Million
216,697 Added 2.09%
10,576,363 $136 Million
Q3 2018

May 16, 2019
SELL
$8.75 - $16.29 $1.9 Million - $3.53 Million
-216,697 Reduced 2.05%
10,359,666 $169 Million
Q3 2018

Nov 14, 2018
BUY
$8.75 - $16.29 $34.3 Million - $63.9 Million
3,920,401 Added 58.9%
10,576,363 $172 Million
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $7.5 Million - $16.4 Million
1,190,476 Added 21.78%
6,655,962 $0
Q4 2017

Feb 14, 2018
BUY
$3.94 - $6.64 $15.9 Million - $26.9 Million
4,046,428 Added 285.15%
5,465,486 $33.4 Million
Q3 2017

Nov 14, 2017
BUY
$2.6 - $4.31 $3.69 Million - $6.12 Million
1,419,058
1,419,058 $5.62 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $215M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email